Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Metabolomics and Lipidomics data in Pancreatic cancer

ABSTRACT: This dataset contains raw LC-MS/MS metabolomics and lipidomics data generated from pancreatic cancer and control samples. The data were acquired to investigate metabolic and lipidomic alterations associated with pancreatic ductal adenocarcinoma and to support integrative multi-omics analysis for biomarker discovery.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Hyeon-Seong Lee

PROVIDER: MSV000100574 | MassIVE | Sat Jan 24 03:19:00 GMT 2026

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Metabolomics and Lipidomics data set in Pancreatic cancer

Project description:This dataset contains raw LC-MS/MS metabolomics and lipidomics data generated from pancreatic cancer and control samples. The data were acquired to investigate metabolic and lipidomic alterations associated with pancreatic ductal adenocarcinoma and to support integrative multi-omics analysis for biomarker discovery.

2026-01-22 | MSV000100560 | MassIVE

Metabolomics and Lipidomics data set for pancreatic cancer_test

2026-01-21 | MSV000100550 | MassIVE

Pancreatic ductal adenocarcinoma

Project description:We sought to determine whether certain miRNAs could serve as a biomarker for the prognosis of pancreatic ductal adenocarcinoma (PDAC) and uncover the uncharacterized miRNAs function in the pancreatic carcinogenesis

2019-10-01 | GSE109918 | GEO

Pancreatic ductal adenocarcinoma

Project description:Pancreatic ductal adenocarcinoma

| PRJNA432344 | ENA

Profiling of Pancreatic Ductal Adenocarcinoma using serum lipidomics

Project description:Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer due to its rapid progression, marked potential for metastasis and the difficulty in diagnosis1-3. However, there are no effective liquid tests currently available for PDAC detection besides CA19-9. Here we introduce a noninvasive detection approach that employs machine learning plus untargeted and targeted serum lipidomics to establish an accurate method to detect PDAC.

2021-07-05 | MSV000087756 | MassIVE

The Neurolipid Atlas: a lipidomics resource for neurodegenerative diseases

Project description:Lipid alterations in the brain have been implicated in many neurodegenerative diseases. To facilitate comparative lipidomic research across brain diseases here we establish a data common named the Neurolipid Atlas, that we have pre-populated with isogenic induced pluripotent stem cell (iPSC)-derived lipidomics data for different brain diseases. Additionally, the resource contains lipidomics data of human and mouse brain tissue. Leveraging multiple datasets, we demonstrate that iPSC-derived neurons, microglia, and astrocytes exhibit distinct lipid profiles that recapitulate in vivo lipotypes. Notably, the AD risk gene ApoE4 drives cholesterol ester (CE) accumulation specifically in human astrocytes, and we also observe CE accumulation in whole human AD brain lipidomics. Multi-omics interrogation of iPSC-derived astrocytes revealed that altered cholesterol metabolism plays a major role in astrocyte interferon-dependent pathways such as the immunoproteasome and major histocompatibility complex class I antigen presentation. Our data commons, available at neurolipidatlas.com, and allows for data deposition by the community and provides a user-friendly tool and knowledge base for a better understanding of lipid dyshomeostasis in neurodegenerative diseases.

2025-07-18 | GSE302826 | GEO

Gene expression in pancreatic ductal adenocarcinoma

Project description:To further develop our understanding of the gene expression signature of pancreatic ductal adenocarcinoma Gene expression signatures in macrodissected resected pancreatic ductal adenocarcinoma specimens

2014-03-14 | E-GEOD-55643 | biostudies-arrayexpress

Development of lncRNA and Mrna expression signatures for pancreatic ductal adenocarcinoma

Project description:To further development of our lncRNA and mRNA expression approach to pancreatic ductal adenocarcinoma(PDAC), we have employed lncRNA and mRNA microarray expression profiling as a discovery platform to identify lncRNA and mRNA expression in pancreatic ductal adenocarcinoma.Human pancreatic ductal adenocarcinoma tissues and normal pancreatic tissues from PDAC donors and other duodenum diseases donors. analyze mRNA and lncRNA expression in pancreatic ductal adenocarcinoma (PDAC) by microarray platform

2014-11-18 | E-GEOD-57144 | biostudies-arrayexpress

MicroRNA expression in Pancreatic Ductal Adenocarcinoma

Project description:Microarray was used to find out the differentially expressed miRNAs in Pancreatic Ductal Adenocarcinoma as compared to healthy control. Resulting miRNAs could be further used to understand the disease as well as could act as secretory biomarker.

2019-12-17 | GSE140196 | GEO